{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:43:44Z","timestamp":1790739824923,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jad-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jad.2018.02.025","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T12:29:03Z","timestamp":1519216143000},"page":"291-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions"],"prefix":"10.1016","volume":"236","author":[{"given":"Patricio","family":"Riva-Posse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin M.","family":"Reiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan A.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Job","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail C.","family":"Galendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Garlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy C.","family":"Saah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boadie W.","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2018.02.025_bib1","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.4088\/JCP.17f11567","article-title":"Ketamine for depression, 1: clinical summary of issues related to efficacy, adverse effects, and mechanism of action","volume":"78","author":"Andrade","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.02.025_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpsychires.2014.07.027","article-title":"Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety","volume":"58","author":"Ballard","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2018.02.025_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.02.025_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2190\/PM.38.1.g","article-title":"Barriers to care-seeking for depressed African Americans","volume":"38","author":"Cruz","year":"2008","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.jad.2018.02.025_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jagp.2017.06.007","article-title":"Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression","author":"George","year":"2017","journal-title":"Am. J. Geriatr. Psychiatry: Off. J. Am. Assoc. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2018.02.025_bib6","series-title":"ECDEU Assessment Manual for Psychopharmacology, Revised","author":"Guy","year":"1976"},{"key":"10.1016\/j.jad.2018.02.025_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0006-8993(01)02079-0","article-title":"A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide","volume":"895","author":"Jevtovic-Todorovic","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.jad.2018.02.025_bib8","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.biopsych.2014.03.026","article-title":"A randomized controlled trial of intranasal ketamine in major depressive disorder","volume":"76","author":"Lapidus","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.02.025_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/acps.12572","article-title":"Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression","volume":"134","author":"Loo","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2018.02.025_bib10","series-title":"Miller's Anesthesia","author":"Miller","year":"2015"},{"key":"10.1016\/j.jad.2018.02.025_bib11","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.02.025_bib12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0269881113478283","article-title":"Serial infusions of low-dose ketamine for major depression","volume":"27","author":"Rasmussen","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2018.02.025_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.02.025_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2018.02.025_bib15","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/npp.2014.338","article-title":"Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?","volume":"40","author":"Sanacora","year":"2015","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2018.02.025_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1176\/appi.ajp.2015.15081082","article-title":"Potential risks of poorly monitored ketamine use in depression treatment","volume":"173","author":"Schak","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.02.025_bib17","article-title":"Side-effects associated with ketamine use in depression: a systematic review","author":"Short","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2018.02.025_bib18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.02.025_bib19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5055\/jom.2013.0180","article-title":"A review of the use of ketamine in pain management","volume":"9","author":"Tawfic","year":"2013","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.jad.2018.02.025_bib20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1213\/00000539-196811000-00025","article-title":"Differentiation of the cardiovascular effects of CI-581","volume":"47","author":"Traber","year":"1968","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jad.2018.02.025_bib21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000542-197212000-00008","article-title":"Circulatory responses to ketamine anesthesia","volume":"37","author":"Tweed","year":"1972","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jad.2018.02.025_bib22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.jhh.1000669","article-title":"Influence of aging on arterial compliance","volume":"12","author":"Van Bortel","year":"1998","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.jad.2018.02.025_bib23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jad.2016.09.008","article-title":"Continuation phase intravenous ketamine in adults with treatment-resistant depression","volume":"206","author":"Vande Voort","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.02.025_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.13m08852","article-title":"Ketamine safety and tolerability in clinical trials for treatment-resistant depression","volume":"76","author":"Wan","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.02.025_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/YCT.0000000000000379","article-title":"Electroconvulsive therapy (ECT) and race: a report of ECT use and sociodemographic trends in Texas","volume":"33","author":"Williams","year":"2017","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2018.02.025_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/YCT.0b013e31815c6641","article-title":"Outcome of electroconvulsive therapy by race in the consortium for research on electroconvulsive therapy multisite study","volume":"24","author":"Williams","year":"2008","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2018.02.025_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/10673229.2010.511059","article-title":"Glutamatergic modulators: the future of treating mood disorders?","volume":"18","author":"Zarate","year":"2010","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2018.02.025_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.0078","article-title":"Use of ketamine in clinical practice: a time for optimism and caution","volume":"74","author":"Zorumski","year":"2017","journal-title":"JAMA Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717322541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717322541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T11:48:00Z","timestamp":1530704880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032717322541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":28,"alternative-id":["S0165032717322541"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2018.02.025","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2018.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}